Last Modified: April 3, 2003
Conference Dates: November 12-15, 2003
Conference Location: Marriott Marquis Hotel, New York, NY
Sponsoring Group: Chemotherapy Foundation
Conference Web Page URL: www.mssm.edu/tcf
Topics Covered: Novel strategies for control and cure of breast, ovarian, prostate, GI, bladder, hematologic malignancies, melanomas, head and neck, lung and brain tumors, cancer research, chemo-prevention, monoclonal antibodies, informatics, molecular targeted agents.
Conference Objectives: Professional education for oncologists for control and cure of cancer.
Who Should Attend: Oncologists, immunologists, hematologists, radiologists, physicians with secondary in oncology, nurses, pharmacists, and other health care professionals
Conference Agenda: Practical applications for the medical oncologist of multimodality therapies in diverse neoplastic diseases. International faculty of clinical investigators present results of clinical trials, new combination chemotherapy regimens, tumor vaccines, gene chips, immunotherapy, agiogenesis inhibition, biomodulation and other developing biotherapies.
Registration Information: Abstracts are accepted from invited faculty only. Physicians, nurses, pharmacists are eligible for CE credits. Registration fees are $475 for physicians, $300 for pharmacists, and $150 for house staff, fellows, physician assistants, nursing personnel, and other health care professionals. Complimentary breakfasts, lunches , and receptions are included
Conference Fees: $475 for physicians, $300 for pharmacists, and $150 for house staff, fellows, physician assistants, nursing personnel, and other health care professionals.
Continuing Education: Yes
Miscellany: Simultaneous Spanish Translation
Nov 4, 2010 - Implementation of the Medicare Modernization Act, which led to reduced reimbursement for androgen-deprivation therapy for prostate cancer, appears to have substantially reduced the rate at which the therapy is used for inappropriate indications, according to research published in the Nov. 4 issue of the New England Journal of Medicine.
Nov 4, 2010